Crovalimab Filed In Japan As More Phase III Results Released At EHA

Potential Lower Dosing Time Benefit

 
• By Lisa Takagi

The Chugai/Roche antibody has been filed for PNH in Japan as more details of its Phase III results are released.

Crovalimab is now under the review for approval in both China and Japan
Crovalimab is now under the review for approval in both China and Japan • Source: Shutterstock

More from Immunological

More from Therapy Areas